<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">120</article-id><article-id pub-id-type="publisher-id">2008MOLVIS0388</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>An &#x003b1;A-crystallin gene mutation, Arg12Cys, causing inherited cataract-microcornea exhibits an altered heat-shock response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Li-Yun</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yam</surname><given-names>Gary Hin-Fai</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tam</surname><given-names>Pancy Oi-Sin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lai</surname><given-names>Ricky Yiu-Kwong</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lam</surname><given-names>Dennis Shun-Chiu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pang</surname><given-names>Chi-Pui</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Fan</surname><given-names>Dorothy Shu-Ping</given-names></name></contrib><aff id="aff1">Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Dorothy Shu-Ping Fan, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 147K Argyle Street, Kowloon, Hong Kong, China; Phone: (852) 2762 3150; FAX: (852) 2715 9490; email: <email xlink:href="dorothyfan@cuhk.edu.hk">dorothyfan@cuhk.edu.hk</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>04</day><month>6</month><year>2009</year></pub-date><volume>15</volume><fpage>1127</fpage><lpage>1138</lpage><history><date date-type="received"><day>18</day><month>11</month><year>2008</year></date><date date-type="accepted"><day>01</day><month>6</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>To investigate the clinical features and molecular basis of inherited cataract-microcornea caused by an &#x003b1;A-crystallin gene (<italic>CRYAA</italic>) mutation in a Chinese family.</p></sec><sec sec-type="methods"><title>Methods</title><p>A three-generation Chinese family with members having autosomal dominant cataract and microcornea was recruited. Genomic DNA from peripheral blood or buccal swab samples of five affected and five unaffected members were obtained. Based on 15 genes known to cause autosomal dominant cataract, single nucleotide polymorphisms (SNPs) or microsatellite markers were selected and genotyped for two-point linkage analysis. Direct sequencing was performed to identify the disease-causing mutation. The expression construct coding for recombinant COOH-terminal myc-His-tagged wild type or R12C &#x003b1;A-crystallin protein (CRYAA) was expressed in COS-7 cells. Detergent solubility and subcellular distribution of wild type and R12C CRYAA were examined by western blotting and immunofluorescence, respectively. Heat-shock response was monitored by quantitative polymerase chain reaction (qPCR) of heat-shock proteins 70 and 90&#x003b1; (HSP70 and HSP90&#x003b1;).</p></sec><sec><title>Results</title><p>The five affected family members showed variable lens opacities and microcornea. Clinical features of cataract were asymmetric in two eyes of some affected subjects. A heterozygous missense substitution, c.34C&#x0003e;T, in <italic>CRYAA</italic>, which is responsible for the R12C amino acid change, segregated with autosomal dominant cataract (ADCC) in this family. This substitution was absent in 103 unrelated controls. When expressed in COS-7 cells, the R12C mutant CRYAA resembled the wild type protein in its solubility when extracted with 0.5% Triton X-100 and with its cytoplasmic localization. However, mutant cells exhibited an altered heat-shock response, evidenced by the delayed expression of HSP70, when compared to cells expressing wild type CRYAA.</p></sec><sec><title>Conclusions</title><p>The R12C mutation in CRYAA was responsible for a variable type of inherited cataract associated with microcornea in this Chinese family. The altered heat-shock response of mutant cells suggested a change of chaperoning capacity and networking, which could be associated with the pathogenesis of hereditary cataract-microcornea syndrome.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Fan</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Congenital or infantile cataract is an opacification of the lens, usually diagnosed at birth or shortly thereafter. Its prevalence is up to 6 in 10,000 live births, causing about 10% of childhood blindness worldwide [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r5">5</xref>]. This heterogeneous disease exhibits considerable phenotypic as well as genetic variation [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>]. Genetically, autosomal dominant inheritance (ADCC) is the most common mode of transmission, though autosomal recessive and X-linked inherited forms have been reported. So far, over 26 genes with specific mutations have been identified to be associated with the onset or progression of hereditary cataract. Among them, 17 are found for isolated autosomal dominant cataract without other ocular or multisystem anomalies including genes coding for crystallins, membrane transport proteins, cytoskeletal proteins, transcription factors, and chromatin modifying proteins [<xref ref-type="bibr" rid="r8">8</xref>].</p><p>About 18% of inherited congenital cataracts appear with a distinct phenotype of congenital cataract-microcornea syndrome (CCMC; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=116150">116150</ext-link>) [<xref ref-type="bibr" rid="r9">9</xref>]. Six genes have been identified to associate with this particular defect including three lens-specific crystallin genes (namely crystallin &#x003b1;A (<italic>CRYAA</italic>) [<xref ref-type="bibr" rid="r10">10</xref>-<xref ref-type="bibr" rid="r13">13</xref>], crystallin &#x003b2;B1 (<italic>CRYBB1</italic>) [<xref ref-type="bibr" rid="r14">14</xref>], and crystallin &#x003b3;D (<italic>CRYGD</italic>) [<xref ref-type="bibr" rid="r10">10</xref>]) as well as genes encoding gap junction protein &#x003b1;8 (<italic>GJA8</italic>) [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>], basic leucine zipper transcriptional factor (<italic>MAF</italic>), [<xref ref-type="bibr" rid="r15">15</xref>-<xref ref-type="bibr" rid="r17">17</xref>] and solute carrier, <italic>SCL16A12</italic> (a carboxylic acid transporter) [<xref ref-type="bibr" rid="r18">18</xref>]. Apart from that, one locus at 11q13 was reported to be related to microcornea and cataract formation, but no specific gene has yet been identified [<xref ref-type="bibr" rid="r19">19</xref>].</p><p>Here, we report a Chinese family exhibiting variable cataract phenotypes and variable microcornea/microphthalmia in an autosomal dominant transmission fashion. The R12C mutant CRYAA protein demonstrated an altered heat-shock response but no change of detergent solubility or subcellular redistribution. This phenotypic variation could represent a crucial role of CRYAA in cataract formation.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects and clinical examinations</title><p>A three-generation Chinese family with inherited cataract (<xref ref-type="fig" rid="f1">Figure 1A</xref>) was recruited to the University Eye Center of The Chinese University of Hong Kong (Hong Kong, China). The research protocol followed the tenets of the Declaration of Helsinki and was approved by the ethics committee of The Chinese University of Hong Kong. Ten family members underwent complete ophthalmic examination including slit lamp biomicroscopy and ophthalmoscopy. All affected individuals (I1, II3, II5, II9, and III5) were followed up for eight years until 2008 by the same senior ophthalmologist in our eye center. During their last visit, additional ophthalmic examinations were performed including corneal diameter measurement, keratometry (Autokerato-refractometer KR-7100; Topcon Optical, Tokyo, Japan), anterior segment optical coherence tomography (1310 nm, Visante OCT Model 1000; Carl Zeiss Meditec, Dublin, CA), and ultrasonography (Ultrasonic Pachymeter SP-3000 and Biometer AL-100; Tomey Corporation, Nagoya, Japan). Slit lamp photography was also performed. Microcornea was defined as the horizontal corneal diameter being shorter than 11&#x000a0;mm [<xref ref-type="bibr" rid="r20">20</xref>,<xref ref-type="bibr" rid="r21">21</xref>] and microphthalmia as the antero-posterior axial length of the adult (normally elder than three) eye globe being shorter than 20&#x000a0;mm [<xref ref-type="bibr" rid="r22">22</xref>,<xref ref-type="bibr" rid="r23">23</xref>].</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>A Chinese autosomal dominant cataract family. <bold>A</bold>: Pedigree of a three-generation Chinese family with autosomal dominant cataract is shown. The asterisk indicates the family members whose DNA samples were analyzed. <bold>B</bold>: The lens image was taken from subject III5 following pupillary dilation. Both lenses showed the lamellar opacity within the fetal nucleus with a clear peripheral cortex. <bold>C</bold>: Subject II3 displayed similar lamellar opacity in the right lens and a central dense opacity with sharp margins in the left lens. <bold>D</bold>: Both images were from subject II5. A single spherical opacity (indicated by black arrows) was evident in the left lens, and only a smaller dot was found in the right lens.</p></caption><graphic xlink:href="mv-v15-1127-f1"/></fig></sec><sec><title>Sample collection and DNA extraction</title><p>From five affected and five unaffected family members, whole blood samples from adult participants and buccal swab samples from children were collected. Genomic DNA was extracted using the QIAamp DNA kit (Qiagen, Valencia, CA). Unrelated subjects without cataracts were recruited as controls.</p></sec><sec><title>Candidate gene screening</title><p>Fifteen known ADCC-associated genes were screened by linkage analysis. Thirty-nine single nucleotide polymorphism (SNP) markers based on 15 genes (<xref ref-type="table" rid="t1">Table 1</xref>) were selected with ABI SNP browser version 3.5 (Applied Biosystems, Foster City, CA). TaqMan SNP genotyping assay was performed by ABI PRISM 7000 sequence detection system (Applied Biosystems) followed by linkage analysis. For chromosomal regions in which SNPs were not informative, microsatellite marker analyses were used. Seventeen microsatellite markers flanking the target genes (<xref ref-type="table" rid="t1">Table 1</xref>) were chosen using the <ext-link ext-link-type="uri" xlink:href="http://research.marshfieldclinic.org">Marshfield</ext-link> genetic map. Genescan was performed with ABI PRISM<sup>&#x000ae;</sup> 3130xl analyzer (Applied Biosystems). Two-point LOD scores were calculated by the MLINK subprogram from <ext-link ext-link-type="uri" xlink:href="http://linkage.rockefeller.edu/soft/list1.html">FASTLINK</ext-link> version 4.1P package. A gene frequency of 0.0001 and penetrance of 100% were assumed for ADCC.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>SNPs and microsatellite markers for candidate gene screening.</title></caption><table frame="hsides" rules="groups"><col width="86" span="1"/><col width="81" span="1"/><col width="89" span="1"/><col width="92" span="1"/><col width="93" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Gene</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Gene ID</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Position</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Microsatellite</bold></th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1"><italic>CRYAA</italic>&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1409&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">21q22.3&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=870137">rs870137</ext-link>&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D21S1890<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="col" rowspan="1">D21S266<hr/></td></tr><tr><td rowspan="4" valign="top" align="center" scope="row" colspan="1"><italic>CRYAB</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="4" valign="top" align="center" colspan="1">1410&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="4" valign="top" align="center" colspan="1">11q22&#x02013;22.3&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2070894">rs2070894</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1940392">rs1940392</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=14133">rs14133</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10502149">rs10502149</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="5" valign="top" align="center" scope="row" colspan="1"><italic>CRYBB1</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="5" valign="top" align="center" colspan="1">1414&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="5" valign="top" align="center" colspan="1">22q11&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4822752">rs4822752</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5752351">rs5752351</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071859">rs2071859</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4822749">rs4822749</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5761618">rs5761618</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="3" valign="top" align="center" scope="row" colspan="1"><italic>CRYBB2</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="3" valign="top" align="center" colspan="1">1415&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="3" valign="top" align="center" colspan="1">22q11.2&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=739315">rs739315</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5752084">rs5752084</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=969623">rs969623</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>CRYBA1</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1411<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">17q11.1&#x02013;12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8080081">rs8080081</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D17S1873<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>CRY GC</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1420<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2q33&#x02013;35<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2242071">rs2242071</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D2S2208<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>CRY GD</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1421<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2q33&#x02013;35<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2305429">rs2305429</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="4" valign="top" align="center" scope="row" colspan="1"><italic>GRY GS</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="4" valign="top" align="center" colspan="1">1427&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="4" valign="top" align="center" colspan="1">3q25-qter&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3774803">rs3774803</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D3S1262<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11917060">rs11917060</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D3S3570<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1447670">rs1447670</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4686428">rs4686428</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="4" valign="top" align="center" scope="row" colspan="1"><italic>MIP</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="4" valign="top" align="center" colspan="1">4284&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="4" valign="top" align="center" colspan="1">12q12&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7953824">rs7953824</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D12S1632<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2269348">rs2269348</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D12S1691<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3809125">rs3809125</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10876890">rs10876890</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1"><italic>GJA8</italic>&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">2703&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">1q21&#x02013;25&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7541950">rs7541950</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2132397">rs2132397</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1"><italic>GJA3</italic>&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">2700&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">13q11&#x02013;13&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4769953">rs4769953</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D13S1316<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1886176">rs1886176</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D13S175<hr/></td></tr><tr><td rowspan="5" valign="top" align="center" scope="row" colspan="1"><italic>BFSP2</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="5" valign="top" align="center" colspan="1">8419&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td rowspan="5" valign="top" align="center" colspan="1">3q21&#x02013;22&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1153876">rs1153876</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D3S1290<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=666067">rs666067</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D3S3713<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4854585">rs4854585</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D3S3657<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6762405">rs6762405</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D3S1292<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=931099">rs931099</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>PITX3</italic><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5309<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10q24&#x02013;25<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3758553">rs3758553</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1"><italic>MAF</italic>&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">4094&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">16q23.2&#x02028;&#x000a0;<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2288066">rs2288066</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D16S3040<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">D16S504<hr/></td></tr><tr><td rowspan="4" valign="top" align="center" scope="row" colspan="1"><italic>HSF4</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;</td><td rowspan="4" valign="top" align="center" colspan="1">3299&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;</td><td rowspan="4" valign="top" align="center" colspan="1">16q22&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">Hcv25749941<hr/></td><td rowspan="4" valign="top" align="center" colspan="1">D16S3107</td></tr><tr><td valign="top" colspan="1" align="center" scope="col" rowspan="1">Hcv25613880<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11642409">rs11642409</ext-link><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1"><ext-link ext-link-type="uri" xlink:href="rs9033">rs9033</ext-link></td></tr></tbody></table><table-wrap-foot><p>This table showed all candidate genes studied in the screening experiment. The gene symbol, gene ID in NCBI, gene chromosome position, SNP markers and microsatellite markers for each gene were listed respectively.</p></table-wrap-foot></table-wrap></sec><sec><title>Gene sequencing</title><p>All coding exons and splice regions of <italic>CRYAA</italic>, <italic>CRYBA1</italic>, and <italic>MAF</italic> were sequenced with specific primers (Invitrogen, Carlsbad, CA; <xref ref-type="table" rid="t2">Table 2</xref>) using BigDye terminator v3.1 cycle sequencing kit (Applied Biosystems) on the ABI PRISM<sup>TM</sup> 3130xl analyzer. Sequences were analyzed with reference to the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank/">NCBI</ext-link> GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/14043059">NM_000394</ext-link> for <italic>CRYAA</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/169790959">NM_005208</ext-link> for <italic>CRYBA1</italic>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/197313769">NM_001031804</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/197313768">NM_005360</ext-link> for <italic>MAF</italic>).</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Specific primers for <italic>CRYAA</italic>, <italic>CRYBA1</italic>, and <italic>MAF</italic> sequencing.</title></caption><table frame="hsides" rules="groups"><col width="101" span="1"/><col width="102" span="1"/><col width="222" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Gene</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Primer</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Primer sequence (5&#x02032;&#x02192;3&#x02032;)</bold></th></tr></thead><tbody><tr><td rowspan="6" valign="top" align="center" scope="row" colspan="1"><italic>CRYAA</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTCCAGGTCCCCGTGGTA<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">1R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AGGAGAGGCCAGCACCAC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTGTCTCTGCCAACCCCAG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTGTCCCACCTCTCAGTGCC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">3F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AATGATCCTGCGATTTTGGAG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">3R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGAAGCAAAGGAAGACAGACACC<hr/></td></tr><tr><td rowspan="12" valign="top" align="center" scope="row" colspan="1"><italic>CRYBA1</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CGCAGGGCTATAAAGAGGAG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">1R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GACAAGAGAAGGCTGTCTTCC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCTTTCAAGGTATTCCCTCACC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CACTGGAGCTTGTGTGGACC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">3F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ATGTTCTAGCTCTCTTGCGC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">3R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTAGTGATTTCTTTCGAGGCC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">4F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGAACACCATGAACAAACACTAC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">4R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACGGAAGTGGAAATTTCAGAG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">5F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CATGTGCTTCCTTGTATAATCC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">5R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACTATTGATGCAACCTCAGG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">6F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CATCTCATACCATTGTGTTGAG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">6R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACTTTCTAGAGTGCTTAGCAAGG<hr/></td></tr><tr><td rowspan="8" valign="top" align="center" scope="row" colspan="1"><italic>MAF</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">1F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTCCTGCAGCCCATCTGG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">1R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTGGTGGCTGTTGCTGATG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CATCAGCAACAGCCACCAG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GAGAAGCGGTCGTCGAAGT<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">3F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACTTCGACGACCGCTTCTC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">3R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGGCGAGCATGGCTCTAG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">4F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCTTTACGCTGCGTTTGATC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">4R</td><td valign="top" align="left" rowspan="1" colspan="1">AACCCCCAGACAAGAGGC</td></tr></tbody></table><table-wrap-foot><p>F: forward primer; R: reverse primer.</p></table-wrap-foot></table-wrap></sec><sec><title>Expression constructs</title><p>A 548 base pair (bp) EcoR1/Xho1 fragment encompassing the human full length 519 bp open reading frame of wild type <italic>CRYAA</italic> was ligated to the EcoR1/Xho1 site of mammalian expression vector, pcDNA6/myc-His (Invitrogen). The c.34C&#x0003e;T mutation was introduced by polymerase chain reaction (PCR)-based site-directed mutagenesis (Stratagene, Lo Jolla, CA) using a specific oligonucleotide: sense 5&#x02032;-ATC CAG CAC CCC TGG TTC AAG <bold><underline>T</underline></bold>GC ACC CTG GGG CCC TTC TAC C-3&#x02032; (the bold underlined alphabet indicated the specific base change). The constructs were verified by direct sequencing.</p></sec><sec><title>Cell culture and transfection</title><p>COS-7 cells (ATCC, Manassas, VA) were maintained in Eagle&#x02019;s Minimum Essential medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS; Invitrogen) and 1% antibiotics at 37&#x000a0;&#x000b0;C in a humidified condition with 5% CO<sub>2</sub> balanced with air. COS-7 cells were verified to contain negligible endogenous CRYAA by reverse transcription polymerase chain reaction (RT&#x02013;PCR) and western blotting. CRYAA expression constructs were transfected to cells at a density of 1.5x10<sup>4</sup> cells/cm<sup>2</sup> by FuGene HD (Roche, Basel, Switzerland) at a ratio of 1 &#x003bc;g of DNA per 3 &#x003bc;l of FuGene HD in Opti-MEM&#x000ae; I supplemented with GlutaMAX<sup>TM</sup> I (Invitrogen). Cells were collected for protein and mRNA analyses 24 h after transfection.</p></sec><sec><title>Triton X-100 solubility assay</title><p>Cells with a density of 2.5&#x000d7;10<sup>6</sup> cells/ml were lysed in a buffer containing 100&#x000a0;mM Tris-HCl (pH 7.4), 3&#x000a0;mM EGTA (Sigma, St Louis, MO), 5&#x000a0;mM MgCl<sub>2</sub>, 0.5% Triton X-100 (Tx; Sigma), protease inhibitor cocktail (Roche), and 1&#x000a0;mM phenylmethylsulfonyl fluoride for 2 min on ice. After centrifugation, the supernatant-containing Tx-soluble protein was collected and denatured in a sodium dodecyl sulfate (SDS) sample buffer containing 50&#x000a0;mM DTT. The pellet containing the Tx-insoluble protein was washed twice with ice-cold PBS, sonicated, and denatured in the SDS sample buffer containing 9 M urea. Tx-soluble and -insoluble proteins equivalent to 7.5&#x000d7;10<sup>4</sup> cells were resolved by 15% SDS&#x02013;polyacrylamide gel electrophoresis (PAGE) and by western blotting with mouse monoclonal antibodies against CRYAA (Abcam, Cambridge, UK), glyceraldehydes 3-phosphate dehydrogenase (GAPDH; Abcam), and &#x003b2;-actin (Sigma) and with rabbit polyclonal antibodies against myc (Santa Cruz, Santa Cruz, CA), His (Abcam), and appropriate horseradish peroxidase-conjugated Ig secondary antibodies (Jackson ImmunoResearch, West Grove, GA). The signals were detected by enhanced chemiluminescence (ECL; Amersham, Piscataway, NJ), and specific bands were quantified by Quantity One Image Analysis software (Bio-Rad, Hercules, CA). CRYAA expression was normalized with GAPDH (for Tx-soluble protein) or &#x003b2;-actin (for Tx-insoluble protein). Three independent experiments were performed, and paired Student&#x02019;s <italic>t</italic>-test was used to determine the statistical significance of the data.</p></sec><sec><title>Immunofluorescence</title><p>Cells were fixed with 2% paraformaldehyde (Sigma) in PBS (0.1 M, pH 7.4), permeabilized, and processed for immunofluorescence [<xref ref-type="bibr" rid="r24">24</xref>]. The sample was detected with mouse monoclonal anti-CRYAA antibody followed by rhodamine Red-X goat anti-mouse IgG secondary antibody (Invitrogen). After nuclear staining by 4'-6-diamidino-2-phenylindole (DAPI; Sigma), samples were examined with fluorescence microscopy (DMRB; Leica, Wetzlar, Germany) equipped with Spot RT color system (Diagnostic Instruments, Sterling Heights, MI).</p></sec><sec><title>Heat-shock analysis</title><p>COS-7 cells expressing wild type or R12C CRYAA were heat-shocked at 42&#x000a0;&#x000b0;C for 20 min and then returned to 37&#x000a0;&#x000b0;C for different time intervals (0, 20, 40, 60, 120, 240, and 480 min). Total RNA was extracted with the RNeasy kit (Qiagen), quantified, and reverse-transcribed with a random primer (Roche) and SuperScript<sup>TM</sup> III reverse transcriptase (Invitrogen). Real-time PCR was performed with SYBR Green/fluorescein PCR mix (Bio-Rad) and specific primers of <italic>HSP70</italic>, <italic>HSP90&#x003b1;</italic>, and <italic>GAPDH</italic> (Invitrogen; <xref ref-type="table" rid="t3">Table 3</xref>) using the ABI PRISM 7000 sequence detection system. Three independent experiments were performed.</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Expression primers of <italic>HSP90A, HSP70</italic>, and <italic>GAPDH</italic>.</title></caption><table frame="hsides" rules="groups"><col width="126" span="1"/><col width="124" span="1"/><col width="192" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Gene</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Primer</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Primer sequence</bold></th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1"><italic>HSP90A</italic>&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACCCAGACCCAAGACCAACCG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ATTTGAAATGAGCTCTCTCAG<hr/></td></tr><tr><td rowspan="4" valign="top" align="center" scope="row" colspan="1"><italic>HSP70</italic>&#x02028;&#x000a0;&#x02028;&#x000a0;&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AAGTACAAAGCGGAGGACG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">1R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GATGGGGTTACACACCTGC<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGCTGATCCAGGTGTACGAG<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CGTTGGTGATGGTGATCTTG<hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1"><italic>GAPDH</italic>&#x02028;&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GAAGGTGAAGGTCGGAGT<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">R</td><td valign="top" align="left" rowspan="1" colspan="1">GAAGATGGTGATGGGATTTC</td></tr></tbody></table><table-wrap-foot><p>F: forward primer; R: reverse primer.</p></table-wrap-foot></table-wrap></sec><sec><title>Computational analysis</title><p>Properties of the wild type and R12C mutant protein were analyzed by some software provided in the <ext-link ext-link-type="uri" xlink:href="http://ca.expasy.org/">Expasy</ext-link> proteomics server. The isoelectric point (pI) and molecular weight (MW) were calculated by <ext-link ext-link-type="uri" xlink:href="http://ca.expasy.org/tools/pi_tool.html">Compute pI/MW</ext-link>. The hydrophobicity change was predicted by <ext-link ext-link-type="uri" xlink:href="http://ca.expasy.org/tools/protscale.html">ProtScale</ext-link>. The effect of the mutation was assessed by <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph/">PolyPhen</ext-link>.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Clinical features of family subjects</title><p>The pedigree exhibited an autosomal dominant pattern of transmission of infantile cataract (<xref ref-type="fig" rid="f1">Figure 1A</xref>). Within the family, different phenotypes of lens opacity were observed in affected individuals between the two eyes of a subject. The proband (III5) was diagnosed with bilateral lamellar cataract at one year of age. The lamellar opacity was located in the fetal nucleus with a more dense center, and the peripheral lens was clear. During his last visit at the age of nine, his horizontal corneal diameters were 9.5 and 10&#x000a0;mm in the left and right eyes, respectively (<xref ref-type="table" rid="t4">Table 4</xref>). His father (II3) had different types of opacities between his eyes, which were first documented at 45 years of age, though he admitted to having eye problems in his younger age. The right lens had a lamellar type of opacification in the fetal nucleus whereas a dense nuclear cataract with a sharp margin was restricted in the left embryonic nucleus without affecting the fetal nucleus (<xref ref-type="fig" rid="f1">Figure 1C</xref>). In his recent follow-up at the age of 53, the cataract showed no progression when compared to previous examinations, and the horizontal corneal diameters were 9.5&#x000a0;mm in both eyes (<xref ref-type="table" rid="t4">Table 4</xref>). Both II3 and III5 exhibited nystagmus, which might be related to the visual impairment during the early childhood [<xref ref-type="bibr" rid="r10">10</xref>]. The sister (II5) of II3 was first diagnosed with bilateral dot-like cataract in the cortical region at the age of 44 (<xref ref-type="fig" rid="f1">Figure 1D</xref>). After eight years, the dotted opacity showed no progression, and the horizontal corneal diameter was approximately in the normal range (10.5&#x000a0;mm; <xref ref-type="table" rid="t4">Table 4</xref>). Another sister (II9) was identified to have variable cataract in both eyes at the age of 38. Dot-like opacity was present in the cortical region of one eye, and the lamellar type opacity was found in the other. The cataract had no obvious progression during the follow-up period. The horizontal corneal diameter was 10&#x000a0;mm when measured at age 46 years (<xref ref-type="table" rid="t4">Table 4</xref>). As a whole, no progression of lens opacity was noted in this family during their follow-up visits in the past eight years, and all eye examinations were performed by the same senior ophthalmologist in our eye center. Subject I1 was diagnosed to have age-related cataract with nuclear sclerosis on his first visit at 71 years of age. Since the lenses lost transparency, it was hard to determine whether lens opacification existed before or after nuclear sclerosis and the type of opacities. His horizontal corneal diameters were measured as 10&#x000a0;mm in both eyes at 79 years of age. All five affected members showed a microcornea phenotype with the horizontal corneal diameter (ranging from 9.5&#x000a0;mm to 10.5&#x000a0;mm) smaller than the defined 11&#x000a0;mm. Subjects II9 and III5 had microphthalmia. The antero-posterior length of the globe was less than 20 mm. All cataract subjects were phakic with mild to mediate vision impairment. Refractive errors included myopia, hyperopia, and astigmatism. The intraocular pressure of each subject was within normal range. They did not have other ocular abnormalities or systemic diseases.</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Clinical features of the affected family members.</title></caption><table frame="hsides" rules="groups"><col width="52" span="1"/><col width="46" span="1"/><col width="51" span="1"/><col width="37" span="1"/><col width="59" span="1"/><col width="66" span="1"/><col width="61" span="1"/><col width="58" span="1"/><col width="53" span="1"/><col width="54" span="1"/><col width="67" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Patients</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Age (years)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Gender</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Eye</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Best corrected visual acuity</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Horizontal corneal diameter (mm)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Corneal curvature radius (mm)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Central corneal thickness (&#x003bc;m)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Average axial length (mm)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Type of cataract</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Nystagmus</bold></th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">I1&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">79&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">M&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Right<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.72<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">550<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.11<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Bilateral nucleus sclerosis<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">No<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">Left<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">550<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.03<hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">II3&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">53&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">M&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Right<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/35<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.86<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">520<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.45<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Lamellar cataract<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Yes<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">Left<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/35<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">510<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.56<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">nuclear dense opacity<hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">III5&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">9&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">M&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Right<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/40<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.91<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">550<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">18.85<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Bilateral lamellar cataract<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Yes<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Left<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/40<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.98<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">550<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.01<hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">II5&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">52&#x02028;&#x000a0;<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">F&#x02028;&#x000a0;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Right<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/35<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.68<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">570<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.83<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Bilateral dot cataract<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">No<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">Left<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/30<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">570<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.26<hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">II9&#x02028;&#x000a0;</td><td rowspan="2" valign="top" align="center" colspan="1">46&#x02028;&#x000a0;</td><td rowspan="2" valign="top" align="center" colspan="1">F&#x02028;&#x000a0;</td><td valign="top" align="center" rowspan="1" colspan="1">Right<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20/30<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.88<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">530<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.73<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Dot cataract<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">No</td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">Left</td><td valign="top" align="center" rowspan="1" colspan="1">20/50</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">6.77</td><td valign="top" align="center" rowspan="1" colspan="1">530</td><td valign="top" align="center" rowspan="1" colspan="1">19.64</td><td valign="top" align="center" rowspan="1" colspan="1">lamellar cataract</td></tr></tbody></table><table-wrap-foot><p>The age given is when the ophthalmic examination was done. The average corneal diameter is 9.95&#x000b1;0.37 mm, the average corneal curvature radius is 6.79&#x000b1;0.11 mm, the average central corneal thickness is 543&#x000b1;20 &#x000b5;m, and the average axial length is 20.247&#x000b1;1.01 mm. M: Male; F: Female.</p></table-wrap-foot></table-wrap></sec><sec><title>Cataract-causing mutation</title><p>Linkage analysis with SNPs and microsatellite markers was performed. Twelve of fifteen candidate cataract-causing genes were excluded. Three genes, namely <italic>CRYAA</italic> (D21S1890; LOD score 1.81), <italic>CRYBA1</italic> (D17S1873; LOD score 0), and <italic>MAF</italic> (D16S3040; LOD score 0), could not be screened because the selected markers were not sufficiently informative and were not directly sequenced. One heterozygous C&#x0003e;T transition at the 34th coding position (c.34C&#x0003e;T) in exon 1 of <italic>CRYAA</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/14043059">NM_000394</ext-link>) was identified (<xref ref-type="fig" rid="f2">Figure 2</xref>). It caused a substitution of arginine with cysteine at the 12th amino acid position (R12C) and segregated with cataract in the family. Neither the unaffected members nor the 130 control subjects carried this base change. No sequence change was identified in <italic>CRYBA1</italic> or <italic>MAF</italic>.</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>A novel R12C mutation of <italic>CRYAA</italic>. Sequencing results showed a substitution of C to T in <italic>CRYAA</italic> (c.34C&#x0003e;T), which led to a R12C amino acid change. In the upper panel, the wild type (WT) <italic>CRYAA</italic> DNA segment (starting from the coding position 28) and its coding amino acid sequence are listed on the left, and the sequencing image is shown on the right. The mutant DNA and polypeptide sequences and the sequencing image were shown in the lower panel. The mutation is indicated in italic. The sequence change in image is indicated by arrows.</p></caption><graphic xlink:href="mv-v15-1127-f2"/></fig></sec><sec><title>Protein feature of the R12C &#x003b1;A-crystallin mutation</title><p>Recombinant myc/His-tagged wild type or R12C CRYAA was transiently expressed in COS-7 cells. In cell lysate extracted by radioimmunoprecipitation assay buffer, both the wild type and R12C CRYAA-myc-His fusion proteins migrated in a single band at approximately 25&#x000a0;kDa when examined by western blotting with monoclonal anti-CRYAA antibody or polyclonal anti-myc or anti-His antibody (<xref ref-type="fig" rid="f3">Figure 3A</xref>). When transfected cells were extracted with 0.5% Tx and subsequently fractionated to obtain Tx-soluble and -insoluble proteins, the majority of R12C CRYAA was detectable in Tx-soluble fractions, similar to that of the wild type (<xref ref-type="fig" rid="f3">Figure 3B</xref>). Only a trace of mutant protein was observable in Tx-insoluble fractions. After being normalized with GAPDH (for Tx-soluble proteins) or &#x003b2;-actin (for Tx-insoluble proteins), band densitometry revealed that the expression amount in either Tx-soluble or insoluble fractions had no significant difference between wild type and R12C CRYAA (p&#x0003e;0.05, Student&#x02019;s <italic>t</italic>-test; <xref ref-type="fig" rid="f3">Figure 3B</xref>). The results were consistent in triplicate experiments.</p><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>R12C CRYAA protein features. <bold>A</bold>: Western blot analysis is shown of total CRYAA expression in transfected COS-7 cells lysed with RIPA. The total amount of mutant R12C CRYAA expressed in COS-7 cells was similar to that of wild type (WT). &#x0201c;-&#x0201d; represents the CRYAA amount in cells transfected with vector only. The expression of housekeeping GAPDH and &#x003b2;-actin is shown as reference. Band densitometry verified that there was no significant difference between WT and R12C mutant amounts after being corrected by GAPDH expression. In band densitometry, bars represent SD. <bold>B</bold>: Detergent solubility of WT and R12C mutant is analyzed. The amount of R12C in Tx-soluble fractions was similar to that of WT. Only a trace of R12C mutant was detected in Tx-insoluble fractions. However, there was no significant difference between WT and R12C mutant amounts after normalization by the housekeeping protein expression. <bold>C</bold>-<bold>F</bold>: The subcellular distribution of WT and R12C CRYAA in COS-7 cells is analyzed as well. The transient expression of recombinant myc/His-tagged WT and R12C in COS-7 cells was detected by anti-CRYAA (<bold>C</bold> and <bold>E</bold>) and anti-myc antibodies (<bold>D</bold> and <bold>F</bold>), respectively. Both the WT (<bold>C</bold><italic>,</italic><bold>D</bold>) and mutant proteins (<bold>E</bold><italic>,</italic><bold>F</bold>) were predominantly localized in the cytoplasm. The red fluorescence indicates the expression of CRYAA, which was overlaid with DAPI-stained nucleus in blue color. Scale bar: 50 &#x000b5;m.</p></caption><graphic xlink:href="mv-v15-1127-f3"/></fig></sec><sec><title>Cytoplasmic distribution of wild type and the R12C &#x003b1;A-crystallin mutant</title><p>Immunofluorescence revealed that both wild type (<xref ref-type="fig" rid="f3">Figure 3C,D</xref>) and R12C CRYAA (<xref ref-type="fig" rid="f3">Figure 3E,F</xref>) were located mainly in the cytoplasm. Some transfected cells also showed minor nuclear staining of CRYAA, which might be due to the overexpression of the protein.</p></sec><sec><title>Heat-shock responses</title><p>COS-7 cells expressing wild type or R12C CRYAA were incubated at 42&#x000a0;&#x000b0;C for 20 min and then at 37&#x000a0;&#x000b0;C for different time intervals. Steady-state RNA expression of <italic>HSP70</italic> and <italic>HSP90&#x003b1;</italic> was investigated by quantitative PCR (qPCR). Each reaction was done in quadruplicate, and the mean signal reading was normalized with that of <italic>GAPDH</italic>. Data from different time points were compared to the non-heat-treated control. We detected a time-dependent change of the <italic>HSP70</italic> expression (<xref ref-type="fig" rid="f4">Figure 4</xref>). For cells expressing wild type CRYAA, the <italic>HSP70</italic> RNA level began to increase shortly after cells were returned to 37&#x000a0;&#x000b0;C and reached a peak level after 40 min. The level was about 25 fold higher than the non-heat-treated control and about 12 fold higher than samples from cells transfected with the vector only. It was then reduced and maintained at a low level, close to that of the 0 min time. This pattern of changing <italic>HSP70</italic> RNA levels was shifted in cells expressing R12C CRYAA. A biphasic change was observed. The <italic>HSP70</italic> RNA level increased shortly after cells were returned to 37&#x000a0;&#x000b0;C incubation. The level was about 12 fold higher than that of the untreated control and about 6 fold higher than samples from cells transfected with vector only. The RNA level dropped to approximately 60% of the peak level followed by a second increase to a level about 40 fold more than that of the control and reached a peak at 120 min. It was then reduced and remained low for 480 min. Similar results were obtained in three independent experiments and when qPCR was performed using another pair of <italic>HSP70</italic> specific primers. For <italic>HSP90&#x003b1;</italic>, steady-state RNA levels remained constant in cells expressing either wild type or R12C CRYAA for all time points after heat stress (<xref ref-type="fig" rid="f4">Figure 4</xref>).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>Time-dependent expression of <italic>HSP70</italic> and <italic>HSP90&#x003b1;</italic>. <bold>A</bold>: Time-dependent expression of <italic>HSP70</italic> is shown of cells expressing WT or R12C CRYAA and cells transfected with vector only. In WT CRYAA expressing cells, the <italic>HSP70</italic> expression reached to a peak level 40 min after heat shock while in R12C expressing cells, <italic>HSP70</italic> expression showed a biphasic curve and reached the highest level at 120 min. <bold>B</bold>: The <italic>HSP90&#x003b1;</italic> expression remained constant among all time points in cells expressing either WT or R12C CRYAA and in cells transfected with vector only.</p></caption><graphic xlink:href="mv-v15-1127-f4"/></fig></sec><sec><title>Computational analysis</title><p>The theoretical pI of R12C CRYAA was slightly reduced to 5.6 compared to wild type CRYAA pI of 5.77. The MW of the mutant was reduced to 19,856 Da from the MW of wild type CRYAA of 19,909 Da. The R12C mutation caused no evident structural change to the protein by <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph/">PolyPhen</ext-link> analysis. However, the <ext-link ext-link-type="uri" xlink:href="http://ca.expasy.org/tools/protscale.html">ProtScale</ext-link> prediction illustrated an increase of local hydrophobicity around the substitution site (<xref ref-type="fig" rid="f5">Figure 5</xref>).</p><fig id="f5" fig-type="figure" position="float"><label>Figure 5</label><caption><p>Altered hydrophobicity of R12C CRYAA protein. <bold>A</bold>: The hydrophobicity of WT CRYAA was predicted using the <ext-link ext-link-type="uri" xlink:href="http://ca.expasy.org/tools/protscale.html">ProtScale</ext-link> program on the <ext-link ext-link-type="uri" xlink:href="http://ca.expasy.org/">Expasy</ext-link> proteomics server. <bold>B</bold>: Compared to WT, R12C dramatically enhances the local hydrophobicity, which is indicated by the rectangle.</p></caption><graphic xlink:href="mv-v15-1127-f5"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In this study, we first reported a heterozygous mutation c.34C&#x0003e;T in exon 1 of <italic>CRYAA</italic> in a Chinese family affected with non-progressive variable inherited cataract and microcornea. This led to an amino acid substitution, R12C, close to the NH<sub>2</sub>-terminus of CRYAA.</p><p>Congenital cataract-microcornea (CCMC; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=116150">116150</ext-link>) syndrome is characterized by lens opacity and a corneal diameter smaller than 11&#x000a0;mm [<xref ref-type="bibr" rid="r20">20</xref>,<xref ref-type="bibr" rid="r21">21</xref>]. It can be associated with other ocular manifestations including myopia, iris coloboma, nystagmus, and microphthalmia [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r25">25</xref>]. One reported family with an autosomal recessive mode of inheritance had a mutation in <italic>CRYAA</italic> (R54C) [<xref ref-type="bibr" rid="r26">26</xref>]. Other CCMC (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=116150">116150</ext-link>) families inherited the disease in an autosomal dominant pattern [<xref ref-type="bibr" rid="r9">9</xref>-<xref ref-type="bibr" rid="r19">19</xref>]. Thirteen mutations in six genes have been identified to cause autosomal dominant CCMC (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=116150">116150</ext-link>). They include missense R12C, R21W, R116H, and R116C mutations of <italic>CRYAA</italic> [<xref ref-type="bibr" rid="r10">10</xref>-<xref ref-type="bibr" rid="r13">13</xref>]; a translational read-through mutation X253R of <italic>CRYBB1</italic> [<xref ref-type="bibr" rid="r14">14</xref>]; a premature truncation mutation, Y134X, of <italic>CRYGD</italic> [<xref ref-type="bibr" rid="r10">10</xref>]; V44E, P189L, and R198Q in <italic>GJA8</italic> [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>]; R288P, K297R, and R299 in <italic>MAF</italic> [<xref ref-type="bibr" rid="r15">15</xref>-<xref ref-type="bibr" rid="r17">17</xref>]; and Q215X in <italic>SCL16A12</italic> [<xref ref-type="bibr" rid="r18">18</xref>]. Interfamilial, intrafamilial, and interocular variations of cataract phenotype could be caused by <italic>CRYAA</italic> mutations. For example, the R116C mutation in <italic>CRYAA</italic> led to fan-shaped cataracts in one family [<xref ref-type="bibr" rid="r12">12</xref>] and zonular central nuclear lens opacities in another family [<xref ref-type="bibr" rid="r13">13</xref>]. The affected members from a family carrying the R116H mutation of <italic>CRYAA</italic> exhibited variable lens phenotypes [<xref ref-type="bibr" rid="r11">11</xref>].</p><p>In this family, all cataract subjects had different severities of microcornea, some of them with microphthalmia. Although all affected subjects carried the R12C mutation, variable opacities among individuals and between eyes were presented within the family. The size and location of lens opacities had no obvious progression during the eight-year follow-up. The clinical features were compatible with the diagnosis of non-progressive cataract-microcornea with clinical variability. This phenotype was different from the Danish family described by Hansen&#x02019;s [<xref ref-type="bibr" rid="r10">10</xref>] group with an affected individual carrying the R12C mutation showing posterior polar opacity progressing to dense nuclear and laminar cataract. The proband&#x02019;s corneal diameter was 9.5&#x000a0;mm. Both the cataract progression and opacity morphology of this individual were different from our non-progressive cataract.</p><p>A total of nine <italic>CRYAA</italic> mutations have been reported to cause inherited cataract. Among them, R12C [<xref ref-type="bibr" rid="r10">10</xref>], R21W [<xref ref-type="bibr" rid="r10">10</xref>], R54C [<xref ref-type="bibr" rid="r26">26</xref>], R116C [<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref>], and R116H [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r11">11</xref>] have been associated with cataract-microcornea syndrome. They are located in the highly conserved arginine residues in two major functional domains of the &#x003b1;A-crystallin, the crystallin domain near the NH<sub>2</sub>-terminus and the heat-shock domain near the COOH-terminus. The COOH-terminal domain was important for substrate-binding ability and chaperoning activity [<xref ref-type="bibr" rid="r27">27</xref>]. The NH<sub>2</sub>-terminus was reported to assist protein oligomerization, stability, and substrate binding [<xref ref-type="bibr" rid="r28">28</xref>]. It is reasonable to assume that changes in the NH<sub>2</sub>-terminus that disturb subunit binding would greatly affect the general functioning of the protein including reduced chaperoning activity. The substitution strongly underscores the importance of the bulky polar amino acid, arginine, in the conformation of the CRYAA protein and oligomeric assembly. Loss of arginine would cause a loss of positive charge and lead to a change of intra- or interpeptide bonding and folding. Functional studies have shown that loss of arginine destabilizes CRYAA, reducing its interactions with substrate proteins and chaperoning activity [<xref ref-type="bibr" rid="r29">29</xref>]. The phenotype of cataract is presumed to be caused by the reduced CRYAA molecular chaperoning ability on other lens proteins [<xref ref-type="bibr" rid="r30">30</xref>]. The associated microcornea might be due to the inductive effects from the abnormally formed lens on the cornea during embryogenesis [<xref ref-type="bibr" rid="r13">13</xref>]. There are other mutations in <italic>CRYAA</italic> reported to cause a cataract phenotype without microcornea. R21L [<xref ref-type="bibr" rid="r31">31</xref>], R49C [<xref ref-type="bibr" rid="r32">32</xref>], and G98R [<xref ref-type="bibr" rid="r33">33</xref>] were associated with the autosomal dominant form while W9X [<xref ref-type="bibr" rid="r34">34</xref>] was associated with the autosomal recessive mode. This divergence of <italic>CRYAA</italic> mutations causing cataract-microcornea syndrome or cataract alone could have different explanations. It is probable that some lens changes may affect cornea development while others do not. Moreover, the corneal size changes might not be obvious in some cases and thus are neglected in routine examinations.</p><p>To demonstrate the effect of R12C substitution on CRYAA chaperoning activity, we used a cell heat stress model. Myc-tagged recombinant CRYAA was expressed in COS-7 cells, which were subjected to heat stress. The heat-shock response was monitored by the expression of heat-shock proteins. We demonstrated that <italic>HSP70</italic> expression was different in cells expressing R12C CRYAA whan compared to wild type CRYAA. Stress-inducible HSP70 is one chaperone molecule that cooperates with multiple other chaperones [<xref ref-type="bibr" rid="r35">35</xref>] to assist in folding and to reduce aggregation of client proteins [<xref ref-type="bibr" rid="r36">36</xref>,<xref ref-type="bibr" rid="r37">37</xref>] and permanently disposes misfolded proteins via the lysosomal [<xref ref-type="bibr" rid="r38">38</xref>] or ubiquitin-proteasome pathway [<xref ref-type="bibr" rid="r39">39</xref>]. It was noted that <italic>Hsp70</italic> was strongly and specifically expressed in the embryonic lens of zebrafish for a short period of time and that it was required for normal lens formation [<xref ref-type="bibr" rid="r40">40</xref>,<xref ref-type="bibr" rid="r41">41</xref>]. Similar expression was also detected in embryonic chicken and human lens [<xref ref-type="bibr" rid="r42">42</xref>-<xref ref-type="bibr" rid="r44">44</xref>]. In zebrafish, the inhibition of <italic>Hsp70</italic> expression may lead to small eye phenotype, characterized by underdeveloped lens [<xref ref-type="bibr" rid="r45">45</xref>]. In our study, R12C CRYAA expressing cells exhibited an altered <italic>HSP70</italic> expression when compared with cells expressing wild type CRYAA. The result suggested that the R12C mutation causes CCMC in our Chinese family possibly through delaying or decreasing <italic>HSP70</italic> expression during lens development.</p><p>Protein analysis by <ext-link ext-link-type="uri" xlink:href="http://ca.expasy.org/tools/protscale.html">ProtScale</ext-link> clearly showed an increase of local hydrophobicity around the Arg-Cys substitution site in CRYAA (<xref ref-type="fig" rid="f5">Figure 5</xref>). As exhibited in other lens proteins, hydrophobicity is associated with crystallin activities. Increased hydrophobic interaction could reduce solubility of CRYBB2 [<xref ref-type="bibr" rid="r46">46</xref>]. Normal folding of CRYGD was maintained by the hydrophobic interface [<xref ref-type="bibr" rid="r47">47</xref>,<xref ref-type="bibr" rid="r48">48</xref>]. For CRYAA, hydrophobicity was involved in protein oligomerization and chaperoning activity [<xref ref-type="bibr" rid="r49">49</xref>,<xref ref-type="bibr" rid="r50">50</xref>]. Hence, the predicted shift of hydrophobicity due to the R12C change might alter the local protein structure and contact interfaces, which subsequently results in changes of protein function. Using <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph/">PolyPhen</ext-link> analysis to predict the effect of amino acid change on protein structure and function, R12C CRYAA did not cause major structural changes when compared to the wild type. Additionally, a slight reduction of theoretical isoelectric point from 5.77 to 5.60 and of molecular weight from 19,909 to 19,856 Da was noted. Their effect on the CRYAA structure has to be further investigated.</p><p>In conclusion, the c.34C&#x0003e;T mutation in <italic>CRYAA</italic> that leads to the R12C substitution segregated with stable inherited cataract in a Chinese family. It was associated with microcornea and microphthalmia. Expression of R12C CRYAA with altered chaperoning capability modified the heat-shock response of affected cells. Such an altered CRYAA property may be related to the development of CCMC (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=116150">116150</ext-link>).</p></sec></body><back><ack><title>Acknowledgments</title><p>The work was supported in part by Research Grants Council, Project No. CUHK 2140557, Hong Kong.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrahamsson</surname><given-names>M</given-names></name><name><surname>Magnusson</surname><given-names>G</given-names></name><name><surname>Sjostrom</surname><given-names>A</given-names></name><name><surname>Popovic</surname><given-names>Z</given-names></name><name><surname>Sjostrand</surname><given-names>J</given-names></name></person-group><article-title>The occurrence of congenital cataract in western Sweden.</article-title><source>Acta Ophthalmol Scand</source><year>1999</year><volume>77</volume><fpage>578</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">10551305</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haargaard</surname><given-names>B</given-names></name><name><surname>Wohlfahrt</surname><given-names>J</given-names></name><name><surname>Fledelius</surname><given-names>HC</given-names></name><name><surname>Rosenberg</surname><given-names>T</given-names></name><name><surname>Melbye</surname><given-names>M</given-names></name></person-group><article-title>Incidence and cumulative risk of childhood cataract in a cohort of 2.6 million Danish children.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2004</year><volume>45</volume><fpage>1316</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">15111583</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>JM</given-names></name><name><surname>Leske</surname><given-names>DA</given-names></name><name><surname>Burke</surname><given-names>JP</given-names></name><name><surname>Hodge</surname><given-names>DO</given-names></name></person-group><article-title>Birth prevalence of visually significant infantile cataract in a defined U.S. population.</article-title><source>Ophthalmic Epidemiol</source><year>2003</year><volume>10</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">12660855</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rahi</surname><given-names>JS</given-names></name><name><surname>Dezateux</surname><given-names>C</given-names></name></person-group><article-title>Measuring and interpreting the incidence of congenital ocular anomalies: lessons from a national study of congenital cataract in the UK.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><fpage>1444</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11381045</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wirth</surname><given-names>MG</given-names></name><name><surname>Russell-Eggitt</surname><given-names>IM</given-names></name><name><surname>Craig</surname><given-names>JE</given-names></name><name><surname>Elder</surname><given-names>JE</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name></person-group><article-title>Aetiology of congenital and paediatric cataract in an Australian population.</article-title><source>Br J Ophthalmol</source><year>2002</year><volume>86</volume><fpage>782</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12084750</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shiels</surname><given-names>A</given-names></name><name><surname>Hejtmancik</surname><given-names>F</given-names></name></person-group><article-title>Genetic origins of cataract.</article-title><source>Arch Ophthalmol</source><year>2007</year><volume>125</volume><fpage>165</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">17296892</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>MA</given-names></name><name><surname>Francis</surname><given-names>PJ</given-names></name><name><surname>Berry</surname><given-names>V</given-names></name><name><surname>Bhattacharya</surname><given-names>SS</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name></person-group><article-title>Molecular genetic basis of inherited cataract and associated phenotypes.</article-title><source>Surv Ophthalmol</source><year>2004</year><volume>49</volume><fpage>300</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">15110667</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hejtmancik</surname><given-names>JF</given-names></name></person-group><article-title>Congenital cataracts and their molecular genetics.</article-title><source>Semin Cell Dev Biol</source><year>2008</year><volume>19</volume><fpage>134</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">18035564</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>RR</given-names></name><name><surname>Vijayalakshmi</surname><given-names>P</given-names></name></person-group><article-title>Novel mutations in GJA8 associated with autosomal dominant congenital cataract and microcornea.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>190</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16604058</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Eiberg</surname><given-names>H</given-names></name><name><surname>Kjaer</surname><given-names>KW</given-names></name><name><surname>Baggesen</surname><given-names>K</given-names></name><name><surname>Hejtmancik</surname><given-names>JF</given-names></name><name><surname>Rosenberg</surname><given-names>T</given-names></name></person-group><article-title>Genetic heterogeneity in microcornea-cataract: five novel mutations in CRYAA, CRYGD, and GJA8.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>3937</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">17724170</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>L</given-names></name><name><surname>Flodman</surname><given-names>P</given-names></name></person-group><article-title>Barria von-Bischhoffshausen F, Burch D, Brown S, Nguyen L, Turner J, Spence MA, Bateman JB. Clinical variability of autosomal dominant cataract, microcornea and corneal opacity and novel mutation in the alpha A crystallin gene (CRYAA).</article-title><source>Am J Med Genet A</source><year>2008</year><volume>146</volume><fpage>833</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">18302245</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanita</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>JR</given-names></name><name><surname>Hejtmancik</surname><given-names>JF</given-names></name><name><surname>Nuernberg</surname><given-names>P</given-names></name><name><surname>Hennies</surname><given-names>HC</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Sperling</surname><given-names>K</given-names></name></person-group><article-title>A novel fan-shaped cataract-microcornea syndrome caused by a mutation of CRYAA in an Indian family.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>518</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">16735993</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Litt</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>P</given-names></name><name><surname>LaMorticella</surname><given-names>DM</given-names></name><name><surname>Murphey</surname><given-names>W</given-names></name><name><surname>Lovrien</surname><given-names>EW</given-names></name><name><surname>Weleber</surname><given-names>RG</given-names></name></person-group><article-title>Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystalline gene <italic>CRYAA.</italic></article-title><source>Hum Mol Genet</source><year>1998</year><volume>7</volume><fpage>471</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9467006</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willoughby</surname><given-names>CE</given-names></name><name><surname>Shafiq</surname><given-names>A</given-names></name><name><surname>Ferrini</surname><given-names>W</given-names></name><name><surname>Chan</surname><given-names>LL</given-names></name><name><surname>Billingsley</surname><given-names>G</given-names></name><name><surname>Priston</surname><given-names>M</given-names></name><name><surname>Mok</surname><given-names>C</given-names></name><name><surname>Chandna</surname><given-names>A</given-names></name><name><surname>Kaye</surname><given-names>S</given-names></name><name><surname>Heon</surname><given-names>E</given-names></name></person-group><article-title>CRYBB1 mutation associated with congenital cataract and microcornea.</article-title><source>Mol Vis</source><year>2005</year><volume>11</volume><fpage>587</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16110300</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>L</given-names></name><name><surname>Eiberg</surname><given-names>H</given-names></name><name><surname>Rosenberg</surname><given-names>T</given-names></name></person-group><article-title>Novel MAF mutation in a family with congenital cataract-microcornea syndrome.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>2019</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17982426</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanita</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Robinson</surname><given-names>PN</given-names></name></person-group>Sperling K, Singh JR<article-title>A novel mutation in the DNA-binding domain of MAF at 16q23.1 associated with autosomal dominant &#x0201c;cerulean cataract&#x0201d; in an Indian family.</article-title><source>Am J Med Genet A</source><year>2006</year><volume>140</volume><fpage>558</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">16470690</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jamieson</surname><given-names>RV</given-names></name><name><surname>Perveen</surname><given-names>R</given-names></name><name><surname>Kerr</surname><given-names>B</given-names></name><name><surname>Carette</surname><given-names>M</given-names></name><name><surname>Yardley</surname><given-names>J</given-names></name><name><surname>Heon</surname><given-names>E</given-names></name><name><surname>Wirth</surname><given-names>MG</given-names></name><name><surname>van Heyningen</surname><given-names>V</given-names></name><name><surname>Donnai</surname><given-names>D</given-names></name><name><surname>Munier</surname><given-names>F</given-names></name><name><surname>Black</surname><given-names>GC</given-names></name></person-group><article-title>Domain disruption and mutation of the bZIP transcription factor, MAF, associated with cataract, ocular anterior segment dysgenesis and coloboma.</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">11772997</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kloeckener-Gruissem</surname><given-names>B</given-names></name><name><surname>Vandekerckhove</surname><given-names>K</given-names></name><name><surname>Nurnberg</surname><given-names>G</given-names></name><name><surname>Neidhardt</surname><given-names>J</given-names></name><name><surname>Zeitz</surname><given-names>C</given-names></name><name><surname>Nurnberg</surname><given-names>P</given-names></name><name><surname>Schipper</surname><given-names>I</given-names></name><name><surname>Berger</surname><given-names>W</given-names></name></person-group><article-title>Mutation of solute carrier SLC16A12 associates with a syndrome combining juvenile cataract with microcornea and renal glucosuria.</article-title><source>Am J Hum Genet</source><year>2008</year><volume>82</volume><fpage>772</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18304496</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>MA</given-names></name><name><surname>Francis</surname><given-names>PJ</given-names></name><name><surname>Betty</surname><given-names>V</given-names></name><name><surname>Bradshaw</surname><given-names>K</given-names></name><name><surname>Patel</surname><given-names>RJ</given-names></name><name><surname>Maher</surname><given-names>ER</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Bhattacharya</surname><given-names>SS</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name></person-group><article-title>A clinical and molecular genetic study of a rare dominantly inherited syndrome (MRCS) comprising of microcornea, tod-cone dystrophy, cataract, and posterior staphyloma.</article-title><source>Br J Ophthalmol</source><year>2003</year><volume>87</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">12543751</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="book">Duke-Elder S, editor. System of Ophthalmology. Volume 3. Part 2. London: Henry Klimpton; 1964. p. 97&#x02013;539.</citation></ref><ref id="r21"><label>21</label><citation citation-type="book">Easty DL, Sparrow JM, editors. Oxford Textbook of Ophthalmology. Oxford: Oxford University Press; 1999. p. 1006&#x02013;11.</citation></ref><ref id="r22"><label>22</label><citation citation-type="book">International Clearinghouse for Birth Defects Monitoring Systems. 2003 Annual Report. Rome: International Centre on Birth Defects; 2003.</citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>AS</given-names></name><name><surname>Fitzpatrick</surname><given-names>DR</given-names></name></person-group><article-title>Anophthalmia and microphthalmia.</article-title><source>Orphanet J Rare Dis</source><year>2007</year><volume>2</volume><fpage>47</fpage><pub-id pub-id-type="pmid">18039390</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yam</surname><given-names>GH</given-names></name><name><surname>Gaplovska-Kysela</surname><given-names>K</given-names></name><name><surname>Zuber</surname><given-names>C</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name></person-group><article-title>Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>1683</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">17389500</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beby</surname><given-names>F</given-names></name><name><surname>Commeaux</surname><given-names>C</given-names></name><name><surname>Bozon</surname><given-names>M</given-names></name><name><surname>Denis</surname><given-names>P</given-names></name><name><surname>Edery</surname><given-names>P</given-names></name><name><surname>Morle</surname><given-names>L</given-names></name></person-group><article-title>New Phenotype associated with an Arg116Cys mutation in the <italic>CRYAA</italic> gene.</article-title><source>Arch Ophthalmol</source><year>2007</year><volume>125</volume><fpage>213</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17296897</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>AO</given-names></name><name><surname>Aldahmesh</surname><given-names>MA</given-names></name><name><surname>Meyer</surname><given-names>B</given-names></name></person-group><article-title>Recessive congenital total cataract with microcornea and heterozygote carrier signs caused by a novel missense <italic>CRYAA</italic> mutation (R54C).</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>949</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">17937925</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berengian</surname><given-names>AR</given-names></name><name><surname>Bova</surname><given-names>MP</given-names></name><name><surname>Mchaourab</surname><given-names>HS</given-names></name></person-group><article-title>Structure and function of the conserved domain in alphaA-crystallin. Site-directed spin labeling identifies a beta-strand located near a subunit interface.</article-title><source>Biochemistry</source><year>1997</year><volume>36</volume><fpage>9951</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9296605</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kundu</surname><given-names>M</given-names></name><name><surname>Sen</surname><given-names>PC</given-names></name><name><surname>Das</surname><given-names>KP</given-names></name></person-group><article-title>Structure, stability and chaperone function of &#x003b1;A-crystallin: Role of N-terminal region.</article-title><source>Biopolymers</source><year>2007</year><volume>86</volume><fpage>177</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">17345631</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>JJ</given-names></name></person-group><article-title>Alteration of protein-protein interactions of congenital cataract crystallin mutants.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>1155</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12601044</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>B</given-names></name><name><surname>Hawes</surname><given-names>NL</given-names></name><name><surname>Roderick</surname><given-names>TH</given-names></name><name><surname>Smith</surname><given-names>RS</given-names></name><name><surname>Heckenlively</surname><given-names>JR</given-names></name><name><surname>Horwitz</surname><given-names>J</given-names></name><name><surname>Davisson</surname><given-names>MT</given-names></name></person-group><article-title>Identification of a missense mutation in the alphaA-crystallin gene of the lop18 mouse.</article-title><source>Mol Vis</source><year>1999</year><volume>5</volume><fpage>21</fpage><pub-id pub-id-type="pmid">10493778</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graw</surname><given-names>J</given-names></name><name><surname>Klopp</surname><given-names>N</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Preising</surname><given-names>MN</given-names></name><name><surname>Lorenz</surname><given-names>B</given-names></name></person-group><article-title>Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P.</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2006</year><volume>244</volume><fpage>912</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16453125</pub-id></citation></ref><ref id="r32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>DS</given-names></name><name><surname>Andley</surname><given-names>UP</given-names></name><name><surname>Shiels</surname><given-names>A</given-names></name></person-group><article-title>Cell death triggered by a novel mutation in the alphaA-crystallin gene underlies autosomal dominant cataract linked to chromosome 21q.</article-title><source>Eur J Hum Genet</source><year>2003</year><volume>11</volume><fpage>784</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">14512969</pub-id></citation></ref><ref id="r33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santhiya</surname><given-names>ST</given-names></name><name><surname>Soker</surname><given-names>T</given-names></name><name><surname>Klopp</surname><given-names>N</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Prakash</surname><given-names>MV</given-names></name><name><surname>Selvaraj</surname><given-names>B</given-names></name><name><surname>Gopinath</surname><given-names>PM</given-names></name><name><surname>Graw</surname><given-names>J</given-names></name></person-group><article-title>Identification of a novel, putative cataract-causing allele in CRYAA (G98R) in an Indian family.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>768</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">16862070</pub-id></citation></ref><ref id="r34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pras</surname><given-names>E</given-names></name><name><surname>Frydman</surname><given-names>M</given-names></name><name><surname>Levy-Nissenbaum</surname><given-names>E</given-names></name><name><surname>Bakhan</surname><given-names>T</given-names></name><name><surname>Raz</surname><given-names>J</given-names></name><name><surname>Assia</surname><given-names>EI</given-names></name><name><surname>Goldman</surname><given-names>B</given-names></name><name><surname>Pras</surname><given-names>E</given-names></name></person-group><article-title>A nonsense mutation (W9X) in CRYAA causes autosomal recessive cataract in an inbred Jewish Persian family.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2000</year><volume>41</volume><fpage>3511</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11006246</pub-id></citation></ref><ref id="r35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Spector</surname><given-names>A</given-names></name></person-group><article-title>ATP causes small heat shock proteins to release denatured protein.</article-title><source>Eur J Biochem</source><year>2001</year><volume>268</volume><fpage>6335</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">11737188</pub-id></citation></ref><ref id="r36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>BC</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name></person-group><article-title>The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding.</article-title><source>EMBO J</source><year>1996</year><volume>15</volume><fpage>2969</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">8670798</pub-id></citation></ref><ref id="r37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartl</surname><given-names>FU</given-names></name></person-group><article-title>Molecular chaperones in cellular protein folding.</article-title><source>Nature</source><year>1996</year><volume>381</volume><fpage>571</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8637592</pub-id></citation></ref><ref id="r38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>HL</given-names></name><name><surname>Terlecky</surname><given-names>SR</given-names></name><name><surname>Plant</surname><given-names>CP</given-names></name><name><surname>Dice</surname><given-names>JF</given-names></name></person-group><article-title>A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins.</article-title><source>Science</source><year>1989</year><volume>246</volume><fpage>382</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">2799391</pub-id></citation></ref><ref id="r39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>EA</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Mitchell</surname><given-names>DM</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Omura</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Goldberg</surname><given-names>AL</given-names></name><name><surname>Ginsberg</surname><given-names>HN</given-names></name></person-group><article-title>The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70.</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>20427</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">9252351</pub-id></citation></ref><ref id="r40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blechinger</surname><given-names>SR</given-names></name><name><surname>Evans</surname><given-names>TG</given-names></name><name><surname>Tang</surname><given-names>PT</given-names></name><name><surname>Kuwada</surname><given-names>JY</given-names></name><name><surname>Warren</surname><given-names>JT</given-names><suffix>Jr</suffix></name><name><surname>Korne</surname><given-names>PH</given-names></name></person-group><article-title>The heat-inducible zebrafish hsp70 gene is expressed during normal lens development under non-stress conditions.</article-title><source>Mech Dev</source><year>2002</year><volume>112</volume><fpage>213</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11850198</pub-id></citation></ref><ref id="r41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blechinger</surname><given-names>SR</given-names></name><name><surname>Warren</surname><given-names>JT</given-names><suffix>Jr</suffix></name><name><surname>Kuwada</surname><given-names>JY</given-names></name><name><surname>Krone</surname><given-names>PH</given-names></name></person-group><article-title>Developmental toxicology of cadmium in living embryos of a stable transgenic zebrafish line.</article-title><source>Environ Health Perspect</source><year>2002</year><volume>110</volume><fpage>1041</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12361930</pub-id></citation></ref><ref id="r42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagchi</surname><given-names>M</given-names></name><name><surname>Ireland</surname><given-names>M</given-names></name><name><surname>Katar</surname><given-names>M</given-names></name><name><surname>Maisel</surname><given-names>H</given-names></name></person-group><article-title>Heat shock proteins of chicken lens.</article-title><source>J Cell Biochem</source><year>2001</year><volume>82</volume><fpage>409</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">11500917</pub-id></citation></ref><ref id="r43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagchi</surname><given-names>M</given-names></name><name><surname>Katar</surname><given-names>M</given-names></name><name><surname>Maisel</surname><given-names>H</given-names></name></person-group><article-title>Heat shock proteins of adult and embryonic human ocular lenses.</article-title><source>J Cell Biochem</source><year>2002</year><volume>84</volume><fpage>278</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11787056</pub-id></citation></ref><ref id="r44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dash</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>S</given-names></name><name><surname>Zelenka</surname><given-names>PS</given-names></name></person-group><article-title>Expression of HSP70 mRNA in the embryonic chicken lens: association with differentiation.</article-title><source>Exp Eye Res</source><year>1994</year><volume>58</volume><fpage>381</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7925675</pub-id></citation></ref><ref id="r45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>TG</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Jeffery</surname><given-names>WR</given-names></name><name><surname>Krone</surname><given-names>PH</given-names></name></person-group><article-title>Zebrafish Hsp70 is required for embryonic lens formation.</article-title><source>Cell Stress Chaperones</source><year>2005</year><volume>10</volume><fpage>66</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">15832949</pub-id></citation></ref><ref id="r46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>BF</given-names></name><name><surname>Liang</surname><given-names>JJ</given-names></name></person-group><article-title>Interaction and biophysical properties of human lens Q155* betaB2-crystallin mutant.</article-title><source>Mol Vis</source><year>2005</year><volume>11</volume><fpage>321</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15889016</pub-id></citation></ref><ref id="r47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flaugh</surname><given-names>SL</given-names></name><name><surname>Kosinski-Collins</surname><given-names>MS</given-names></name><name><surname>King</surname><given-names>J</given-names></name></person-group><article-title>Contributions of hydrophobic domain interface interactions to the folding and stability of human gammaD-crystallin.</article-title><source>Protein Sci</source><year>2005</year><volume>14</volume><fpage>569</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">15722442</pub-id></citation></ref><ref id="r48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flaugh</surname><given-names>SL</given-names></name><name><surname>Kosinski-Collins</surname><given-names>MS</given-names></name><name><surname>King</surname><given-names>J</given-names></name></person-group><article-title>Interdomain side-chain interactions in human gammaD crystallin influencing folding and stability.</article-title><source>Protein Sci</source><year>2005</year><volume>14</volume><fpage>2030</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">16046626</pub-id></citation></ref><ref id="r49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>KK</given-names></name><name><surname>Kumar</surname><given-names>RS</given-names></name><name><surname>Kumar</surname><given-names>GS</given-names></name><name><surname>Quinn</surname><given-names>PT</given-names></name></person-group><article-title>Synthesis and characterization of a peptide identified as a functional element in alphaA-crystallin.</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>3767</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">10660525</pub-id></citation></ref><ref id="r50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shroff</surname><given-names>NP</given-names></name><name><surname>Cherian-Shaw</surname><given-names>M</given-names></name><name><surname>Bera</surname><given-names>S</given-names></name><name><surname>Abraham</surname><given-names>EC</given-names></name></person-group><article-title>Mutation of R116C results in highly oligomerized alpha A-crystallin with modified structure and defective chaperone-like function.</article-title><source>Biochemistry</source><year>2000</year><volume>39</volume><fpage>1420</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10684623</pub-id></citation></ref></ref-list></back></article> 